Use of a composition containing oils of chamomile flower and black cumin with reduced endotoxins

Abstract

A composition comprising an aqueous extract of camomile flowers is useful for the treatment of a proliferative and/or inflammatory condition.

1 . A method for the treatment of a proliferative and/or inflammatory condition comprising:
 preparing a composition comprising the volatile oil of camomile flowers, and black cumin oil, and   administering said composition to a patient in need thereof.   
     
     
         2 . The method according to  claim 1 , wherein said camomile flowers are Flores tubiformis. 
     
     
         3 . The method according to  claim 1 , wherein said volatile oil of camomile flowers is obtained by water steam distillation that is carried out under reduced pressure. 
     
     
         4 . The method according to  claim 1 , wherein said composition contains endotoxins in an amount of 100 EU/ml (endotoxin units per ml according to Ph. Eur.) or less. 
     
     
         5 . The method according to  claim 1 , wherein said composition contains no material having a molecular weight in excess of 10,000. 
     
     
         6 . The method according to  claim 1 , wherein said composition is free or essentially free of compounds selected from the group consisting of coumarins, flavonoids, and residual water. 
     
     
         7 . The method according to  claim 1 , wherein said composition additionally comprises ascorbyl palmitate and/or acetylcysteine. 
     
     
         8 . The method according to  claim 1 , wherein said composition additionally comprises at least one pharmaceutical aid, preferably selected from the group consisting of pharmaceutical agents and pharmaceutical excipients. 
     
     
         9 . The method according to  claim 1 , wherein said method comprises administration by oral, topical, rectal, inhalation, or injection to a patient in need thereof. 
     
     
         10 . The method according to  claim 9 , wherein said method comprises administration by injection or inhalation. 
     
     
         11 . The method according to  claim 1 , wherein said condition is an inflammatory condition, preferably selected from the group consisting of Morbus Crohn and multiple sclerosis. 
     
     
         12 . The method according to  claim 1 , wherein said condition is cancer, preferably selected from the group consisting of glioblastoma, lung cancer and prostate cancer. 
     
     
         13 . The method according to  claim 1 , wherein said condition is caused by autoimmunopathy. 
     
     
         14 . The method according to  claim 12 , wherein said condition is triggered by interleukin 6. 
     
     
         15 . The method according to  claim 12 , wherein said condition is triggered by leucotrienes. 
     
     
         16 . The method according to  claim 12 , wherein said condition is dependent on the presence of interleukin 6 and/or leucotrienes. 
     
     
         17 . The method according to  claim 1 , wherein said composition contains less than 0.1% w/w water. 
     
     
         18 . The method according to  claim 1 , wherein said composition comprises purified black cumin oil.